131 related articles for article (PubMed ID: 31854281)
1. Molecular Docking Studies Reveal Rhein from rhubarb (
Khan MS; Mehmood B; Yousafi Q; Bibi S; Fazal S; Saleem S; Sajid MW; Ihsan A; Azhar M; Kamal MA
Med Chem; 2021; 17(3):273-288. PubMed ID: 31854281
[TBL] [Abstract][Full Text] [Related]
2. Elevated system exposures of baicalin after combinatory oral administration of rhein and baicalin: Mainly related to breast cancer resistance protein (ABCG2), not UDP-glucuronosyltransferases.
Zhang Y; Zhang M; Hu G; Zhang Z; Song R
J Ethnopharmacol; 2020 Mar; 250():112528. PubMed ID: 31884038
[TBL] [Abstract][Full Text] [Related]
3. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
[TBL] [Abstract][Full Text] [Related]
4. Molecular docking studies of phytocompounds of
Rolta R; Salaria D; Kumar V; Patel CN; Sourirajan A; Baumler DJ; Dev K
J Biomol Struct Dyn; 2022 May; 40(8):3789-3803. PubMed ID: 33225862
[No Abstract] [Full Text] [Related]
5. The influence of rhein on the absorption of rehmaionoside D: In vivo, in situ, in vitro, and in silico studies.
Yang H; Zhai B; Wang M; Fan Y; Wang J; Cheng J; Zou J; Zhang X; Shi Y; Guo D; Tang Z
J Ethnopharmacol; 2022 Jan; 282():114650. PubMed ID: 34536515
[TBL] [Abstract][Full Text] [Related]
6. The Selective Class IIa Histone Deacetylase Inhibitor TMP195 Resensitizes ABCB1- and ABCG2-Overexpressing Multidrug-Resistant Cancer Cells to Cytotoxic Anticancer Drugs.
Wu CP; Lusvarghi S; Wang JC; Hsiao SH; Huang YH; Hung TH; Ambudkar SV
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905792
[TBL] [Abstract][Full Text] [Related]
7. In Silico Targeting Human Multidrug Transporter ABCG2 in Breast Cancer: Database Screening, Molecular Docking, and Molecular Dynamics Study.
Ibrahim MAA; Badr EAA; Abdelrahman AHM; Almansour NM; Mekhemer GAH; Shawky AM; Moustafa MF; Atia MAM
Mol Inform; 2022 Feb; 41(2):e2060039. PubMed ID: 34491628
[TBL] [Abstract][Full Text] [Related]
8. Derivative of 5-cyano-6-phenylpyrimidin antagonizes ABCB1- and ABCG2-mediated multidrug resistance.
Wang JQ; Wang B; Lei ZN; Teng QX; Li JY; Zhang W; Ji N; Cai CY; Ma LY; Liu HM; Chen ZS
Eur J Pharmacol; 2019 Nov; 863():172611. PubMed ID: 31476282
[TBL] [Abstract][Full Text] [Related]
9. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD
Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284
[TBL] [Abstract][Full Text] [Related]
10. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular fingerprints of natural products for the inhibition of breast cancer resistance protein (BCRP).
Banik A; Ghosh K; Patil UK; Gayen S
Phytomedicine; 2021 May; 85():153523. PubMed ID: 33662771
[TBL] [Abstract][Full Text] [Related]
12. Reversal effect of FW-04-806, a macrolide dilactone compound, on multidrug resistance mediated by ABCB1 and ABCG2 in vitro and in vivo.
Zhang Z; Ma C; Li P; Wu M; Ye S; Fu L; Xu J
Cell Commun Signal; 2019 Sep; 17(1):110. PubMed ID: 31472682
[TBL] [Abstract][Full Text] [Related]
13. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.
Gupta P; Zhang YK; Zhang XY; Wang YJ; Lu KW; Hall T; Peng R; Yang DH; Xie N; Chen ZS
Cell Physiol Biochem; 2018; 45(4):1515-1528. PubMed ID: 29486476
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Discovery of ABCG2 Inhibitors: A Homology Protein-Based Pharmacophore Modeling and Molecular Docking Approach.
Le MT; Hoang VN; Nguyen DN; Bui TH; Phan TV; Huynh PN; Tran TD; Thai KM
Molecules; 2021 May; 26(11):. PubMed ID: 34071039
[TBL] [Abstract][Full Text] [Related]
15. Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance.
Ji N; Yang Y; Lei ZN; Cai CY; Wang JQ; Gupta P; Xian X; Yang DH; Kong D; Chen ZS
Biochem Pharmacol; 2018 Dec; 158():274-285. PubMed ID: 30431011
[TBL] [Abstract][Full Text] [Related]
16. ABCG2 requires a single aromatic amino acid to "clamp" substrates and inhibitors into the binding pocket.
Gose T; Shafi T; Fukuda Y; Das S; Wang Y; Allcock A; Gavan McHarg A; Lynch J; Chen T; Tamai I; Shelat A; Ford RC; Schuetz JD
FASEB J; 2020 Apr; 34(4):4890-4903. PubMed ID: 32067270
[TBL] [Abstract][Full Text] [Related]
17. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2.
Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW
Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547
[TBL] [Abstract][Full Text] [Related]
18. Optimization of the chromone scaffold through QSAR and docking studies: Identification of potent inhibitors of ABCG2.
Roussel E; Tran-Nguyen VK; Bouhedjar K; Dems MA; Belaidi A; Matougui B; Peres B; Azioune A; Renaudet O; Falson P; Boumendjel A
Eur J Med Chem; 2019 Dec; 184():111772. PubMed ID: 31630055
[TBL] [Abstract][Full Text] [Related]
19. Virtual screening of ABCC1 transporter nucleotidebinding domains as a therapeutic target in multidrug resistant cancer.
Rungsardthong K; Mares-Sámano S; Penny J
Bioinformation; 2012; 8(19):907-11. PubMed ID: 23144549
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationships in ABCG2: insights from molecular dynamics simulations and molecular docking studies.
Ferreira RJ; Bonito CA; Cordeiro MNDS; Ferreira MU; Dos Santos DJVA
Sci Rep; 2017 Nov; 7(1):15534. PubMed ID: 29138424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
